Find Academic Supervisors

Silvestro Micera is a Full Professor at the Swiss Federal Institute of Technology Lausanne (EPFL) and holds the Bertarelli Foundation Chair in Translational Neuroengineering. He directs the Translational Neural Engineering Laboratory and teaches courses including Neural signals and signal processing and Translational neuroengineering . His research bridges neural interfaces, robotics, and neuroprosthetics to restore motor functions in spinal cord injuries, stroke, and amputations. Micera's research integrates implantable neural interfaces, robotic rehabilitation, and hybrid neuro-prosthetic systems. Key focus areas include: Robotic neurorehabilitation for mobility restoration Neural control mechanisms in movement CNS/PNS neural interface development Bioelectronic modulation for sensory feedback His recent publications emphasize machine learning-driven motor recovery prediction, closed-loop sensory feedback systems, and minimally invasive neuroprosthetics. Trends include AI-optimized stimulation protocols, multimodal data fusion for rehabilitation, and clinical translation of neural bypass technologies. Awards: IEEE EMBS Early Career Achievement Award (2009) IEEE EMBS Technical Achievement Award (2021) Micera leads EU-funded projects such as TIME, CLONS, and NeuWalk, focusing on neural prostheses. He advises 8 current and 18 former PhD students in neuroengineering. His lab collaborates with MIT, Harvard, and industry partners (e.g., Plexon) to advance translational neurotechnologies.

• Neural Engineering
• Neuroprosthetics
• Robotics
• +3 more

Dr. Junfang Wu is a Professor in the Department of Anesthesiology and holds a secondary appointment in Neurobiology at the University of Maryland School of Medicine. She serves as Associate Director of UM-MIND (University of Maryland - Medicine Institute for Neuroscience Discovery), Director of the Anesthesiology Center for Neuroscience Research, and Vice-Chair for Translational Research in the Department of Anesthesiology. Her academic journey includes a BM in Medicine, MS in Pharmacology from Jiangxi Medical College, and PhD in Neuropharmacology from Nanjing Medical University, followed by postdoctoral training at China's Institute of Materia Medica and NIH. Research Focus: Neurotrauma, neuroinflammation, autophagy-lysosomal pathway, extracellular vesicles, Hv1/NOX2/ROS, TrkB.T1 Key Techniques: Rodent models of SCI/TBI, behavioral evaluations, EV characterization, quantitative imaging, molecular/cellular biology Dr. Wu's research explores the cellular and molecular mechanisms of neurological dysfunction following CNS trauma, with emphasis on autophagy-lysosomal disruption, microglial Hv1 channels, and EV-mediated neuroinflammatory signaling. Her 2025 Aging and disease study reveals age-dependent transcriptional changes post-anesthesia, while 2024 Brain, Behavior, and Immunity work demonstrates how SCI alters EV cargoes to drive brain neuroinflammation. Her team recently discovered that Hv1 proton channel ablation in microglia provides neuroprotection in SCI models. Her scientific contributions are recognized through the 2025 Matjasko Professorship in Anesthesiology Research. She has secured multiple NIH grants including: R01 NS145443 (2025-2030): cGAS signaling in brain trauma-induced neuroinflammation R01 AG077541 (2022-2027): TBI olfactory dysfunction and dementia progression 2RF1 NS094527 (2016-2027): Autophagy mechanisms in SCI R01 NS110825 (2020-2026): Hv1 channel in SCI/TBI Dr. Wu's laboratory personnel include Research Associates Yun Li and Zhuofan Lei, Post-doctoral Fellows Balaji Krishnamachary and Zihui Wang, Research Assistant Hui Li, and medical student Ruth Park. Her work spans from bench research on lysosomal damage to clinical implications for Alzheimer's disease-related dementia (AD/ADRD) and potential therapeutic strategies.

• Neurotrauma
• Neuropharmacology
• Neuroinflammation
• +7 more

Dr. Tanzil M. Arefin is an Assistant Professor of Neuroscience at the University of Rochester School of Medicine and Dentistry and Associate Director of the Preclinical Imaging Core at the Center for Advanced Brain Imaging and Neurophysiology (CABIN). His research focuses on developing neuroimaging techniques to study brain functions and microstructures in animal models of human disorders, including neurodegenerative and psychiatric illnesses. He holds affiliations with the Del Monte Institute for Neuroscience and the Neuroscience Ph.D. Program. **Education**: Ph.D., Neuroscience, University of Freiburg and University of Strasbourg (2017) M.Sc., Biomedical Engineering, Czech Technical University and University of Groningen (2012) B.Sc., Electrical and Electronic Engineering, Islamic University of Technology (2007) **Research Interests**: Dr. Arefin's lab employs multimodal MRI methodologies (resting-state fMRI, diffusion MRI, ASL perfusion MRI, MR spectroscopy) alongside optogenetics and chemogenetics to elucidate molecular mechanisms impairing brain plasticity. Current projects include studying cerebellar connectivity's role in non-motor behaviors and developing interventions for alcohol-dependent brains. **Awards**: Magna cum Laude, Summa Cum Laude, Erasmus Mundus Fellowships (both Doctoral and Masters). **Grants & Advising**: Not explicitly listed in texts, but lab activities suggest involvement in NIH-funded projects. Advising details are pending explicit student listings. **Lab & Affiliations**: Arefin Lab focuses on translational imaging tools. Affiliated with UR CABIN and URMC's Neuroscience programs. Location: 430 Elmwood Ave, Rochester, NY.

• Neuroimaging
• Neuroscience
• Brain Disorders
• +5 more

Dr. Michael D. Burton is an **Associate Professor** and **Eugene McDermott Distinguished Professor** in the Department of Neuroscience at the University of Texas at Dallas (UT Dallas), affiliated with the **School of Behavioral and Brain Sciences**. He is a founding member of the **Center for Advanced Pain Studies (CAPS)** and holds roles in the **Center for Vital Longevity (CVL)**. His research focuses on neuroimmunology, pain mechanisms, and metabolic disorders, emphasizing how immune-nervous system interactions influence chronic pain, depression, anxiety, and aging-related conditions. Dr. Burton’s work bridges preclinical and translational research, using rodent models and human clinical samples. Education: PhD in Animal Science (Immunophysiology and Behavior), University of Illinois at Urbana-Champaign (2012) B.S. in Animal Science and Biotechnology, University of Illinois at Urbana-Champaign (2006) Postdoc in Pain Neurobiology, UT Dallas (2017) Postdoc in Diabetes/Metabolism Research, UT Southwestern Medical Center (2015) Research Interests: Dr. Burton investigates how peripheral stimuli (diet, alcohol, immune activation) affect pain and behavior through neuroimmune pathways. Key areas include: Sex differences in pain sensitivity and neuroinflammation Risk factors for chronic pain (e.g., high-fat diets, aging) Neuroimmune biomarkers for pain and delirium Development of non-opioid analgesics (e.g., cannabinoids) Awards: 2024 ROAR Research Award, UT Dallas 2023 Eugene McDermott Distinguished Professorship 2022 SFNova/Rising Star (Society for Neuroscience) 2019 Mitchell Max Award for Pain Research Grants & Leadership:** Co-Director, **Enhancing Neuroscience Undergraduate Research Experiences (ENSURE)** program ($900K grant) NIH R35, R21 grants (pain and metabolism) Editorial roles: *Neurobiology of Pain*, *Journal of Neuroinflammation*, and others Labs & Teams:** Neuroimmunology and Behavior Lab (UT Dallas) Member, NIH Pain Consortium and Endocrine Society’s Basic Science Group

• Neuroimmunology
• Pain Management
• Metabolic Disorders
• +5 more

Steven F. Maier is a Distinguished Research Professor in Behavioral Neuroscience at the University of Colorado, serving as Director of the Center for Neuroscience. His PhD was awarded by the University of Pennsylvania in 1968. His research focuses on neurochemistry and neuropharmacology of stress, drug addiction, and bidirectional brain-immune interactions. Key areas include psychoneuroimmunology, neuroinflammation, and the mechanisms underlying stress-induced cognitive and behavioral changes. Research highlights include studies on SARS-CoV-2-induced neuroinflammation, the role of probiotics in mitigating CNS inflammation, and the impact of stress controllability on resilience. His work also explores exercise-mediated neuroprotection, TLR signaling in opioid-induced cognitive dysfunction, and Mycobacterium vaccae's effects on stress resilience. The Maier/Watkins Laboratory employs rodent models to investigate these topics. Recent articles emphasize neuroinflammatory priming, the interplay between stress and immune signaling, and translational applications of immunomodulation. His studies often integrate behavioral, biochemical, and molecular approaches to dissect complex neurobiological pathways. Ongoing work addresses age-related neuroinflammatory sensitization and novel therapeutic strategies for chronic pain and cognitive decline.

• Neurochemistry
• Neuropharmacology
• Stress Biology
• +5 more

Kevin S. Lee, Ph.D., is a Professor in the Department of Neuroscience at the University of Virginia School of Medicine. His research is centered on understanding the mechanisms of neuronal injury and developing therapeutic interventions for neurological disorders such as stroke, epilepsy, and glioblastoma. He leads a multidisciplinary laboratory focused on neuroinflammatory pathways and non-invasive brain circuit modulation. Research Interests: Mechanisms of neuronal injury in stroke and epilepsy Neuroinflammation in cognitive dysfunction post-cardiopulmonary bypass Therapeutic development using trans-sodium crocetinate Non-invasive disconnection of brain circuitry using focused ultrasound Pathophysiology of cortical malformations and seizures Neuroinflammatory contributions to glioblastoma multiforme Publication Trends: His recent publications demonstrate a strong focus on translational neuroscience, particularly combining molecular interventions with advanced neuromodulation techniques. A recurring theme is the use of non-invasive, targeted neuronal injury to study and treat seizure disorders and cognitive decline, often employing rodent models and collaborations with imaging experts. The work spans neuroengineering, neuroimmunology, and neuropharmacology, reflecting a highly interdisciplinary approach. Scientific Awards: No awards explicitly mentioned in the provided text. Advising and Grants: While specific students and grant funding are not listed, Dr. Lee appears to lead an active research lab with multiple ongoing projects and collaborations. His publication record suggests sustained funding and mentorship of junior researchers. He frequently collaborates with experts in neurosurgery, radiology, and immunology, indicating a team-based research environment. Laboratory and Research Team: The Lee Lab conducts multidisciplinary investigations into neuronal injury and repair. Research projects include stroke treatment, glioblastoma, and neuroinflammatory mechanisms. The lab collaborates extensively, particularly with Dr. Max Wintermark and others in neuroscience and radiology, suggesting integration within a larger research consortium at UVA.

• Neuroscience
• Neuronal Injury
• Neuroinflammation
• +7 more

James L. Salzer is a Professor in both the Department of Neuroscience and Physiology and the Department of Neurology at NYU Grossman School of Medicine, New York University. He is a principal investigator at the Salzer Lab within the NYU Langone Health Neuroscience Institute, where he leads cutting-edge research on axon-glial interactions and myelination. Dr. Salzer earned his MD and PhD from Washington University in St. Louis, establishing a strong foundation in both clinical medicine and basic science research. His research centers on the molecular and cellular mechanisms underlying myelination, demyelination, and remyelination in the central and peripheral nervous systems. Key interests include the role of glial cells in organizing axonal electrogenic domains such as nodes of Ranvier and the axon initial segment, the signaling pathways (including Sonic hedgehog and Gli1) regulating neural stem cell repair, and the interplay between microglia and neural stem cells during injury and repair. His work has significant implications for understanding and treating multiple sclerosis and other demyelinating diseases. His recent publications, spanning high-impact journals such as Cold Spring Harbor Perspectives in Biology , Developmental Cell , and The Journal of Neuroscience , reflect a strong focus on Schwann cell biology, glial-axon signaling, and regenerative mechanisms in myelin disorders. The articles highlight advanced techniques including live imaging, transcriptomics, and electron microscopy, demonstrating a multidisciplinary approach to neuroscience. Dr. Salzer mentors a dynamic research team comprising PhD and MD/PhD students, postdoctoral researchers, and research associates, fostering the next generation of neuroscientists. His lab receives support from major research grants, enabling extensive studies using transgenic mouse models, cocultures, and advanced imaging to dissect the biology of myelinated axons. The Salzer Lab is actively involved in both fundamental discovery and translational research, aiming to develop therapeutic strategies for promoting nerve repair in demyelinating conditions. His work integrates molecular, cellular, and systems-level approaches to understand how neural circuits are assembled and maintained.

• Molecular Neuroscience
• Cellular Neuroscience
• Translational Neuroscience
• +17 more

Lorraine Iacovitti is a Professor in the Department of Neuroscience at Thomas Jefferson University, affiliated with the Vickie and Jack Farber Institute for Neuroscience and the Jefferson Stem Cell & Regenerative Neuroscience Center. Her research focuses on developing cell-based therapies for neurodegenerative disorders through stem cell differentiation studies. Her educational background includes: Post-Doctoral, Washington University-St. Louis, Anatomy & Neurobiology (1981) PhD in Neurobiology from Cornell University Medical College (1979) BS in Biology from Monmouth College (1973) Dr. Iacovitti's laboratory investigates dopamine neuron development to create molecular blueprints for treating Parkinson's disease. Using human embryonic stem cells and precursor cells, her team employs a multidisciplinary approach combining tissue culture, molecular engineering (qPCR, microarray, transfection), anatomical analysis (immunocytochemistry, confocal microscopy), biochemical assays (HPLC), stereotaxic surgery, and behavioral testing in rodent models. Current work focuses on inducing dopaminergic traits in stem cells and optimizing transplantation protocols for Parkinson's disease models. Recent publications demonstrate consistent translational focus on stem cell applications for neurological conditions, particularly stroke recovery and Parkinson's disease. Key themes include extracellular vesicle therapeutics, molecular pathways protecting dopaminergic neurons, and motor function restoration in animal models of ischemic injury. Dr. Iacovitti leads an active research laboratory within the Vickie and Jack Farber Institute for Neuroscience, utilizing advanced techniques including PET/SPECT imaging, arterial occlusion surgery, and comprehensive behavioral assessment. Her work bridges basic developmental neuroscience with preclinical cell therapy development for neurodegenerative conditions.

• Neurodegenerative Diseases
• Stem Cells
• Parkinson's Disease
• +2 more

Ali Abdollahzadeh is an Academy Research Fellow at the A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, within the Faculty of Health Sciences. His research focuses on medical image analysis and biophysics, particularly in neuroimaging techniques like diffusion MRI and electron microscopy. He develops advanced computational tools for analyzing white matter ultrastructures and neurovascular interactions. Key projects include studying the role of meningeal lymphatics in neuroinflammation and migraine mechanisms, as well as creating open-source software like SproutAngio and gACSON for bioimage informatics. His work bridges biophysics, computational neuroscience, and clinical applications. Recent studies explore axonal remodeling under stress, neurovascular dynamics, and deep learning applications in neurological disease analysis. He collaborates with the Computational Neuroanatomy Lab and Multiscale Imaging Group, advancing interdisciplinary research in brain imaging and neurodegenerative disorders. Publications highlight innovations in segmentation algorithms, 3D imaging techniques, and translational studies linking microscopic findings to clinical outcomes. His research aims to enhance understanding of CNS structure-function relationships and improve diagnostic tools through advanced imaging methodologies.

• Medical Image Analysis
• Biophysics
• Diffusion MRI
• +6 more

Dan Ma is a Lecturer in Aston Medical School (AMS) at Aston University, specializing in medical education and research focused on brain stem cells and remyelination. She holds a D.Phil. in neuroanatomy from the University of Oxford and an MD in neuroendocrinology from The Fourth Military Medical University, Xi’an, China. Her research explores human induced pluripotent stem cell (iPSC)-derived neural stem cells and endothelial cells in neurodegenerative therapies, oligodendrocyte progenitor cell (OPC) biology, and hydrogen sulfide pathways in remyelination. She collaborates with Dr. Chao Zhao at the University of Cambridge’s Department of Clinical Neurosciences and serves as a Visiting Researcher there (2018–2019). Her work bridges translational medicine and stem cell therapy, with recent projects investigating EC-derived iPSCs in remyelination and neuroregeneration. Education: PGCert in Teaching & Learning in Higher Education, Aston University D.Phil. in Neuroanatomy, University of Oxford Master of Medicine (MD) in Neuroendocrinology, The Fourth Military Medical University Bachelor of Medicine and Surgery (MBBS), The Fourth Military Medical University Research Interests: Human iPSC-derived cells in neurodegenerative therapies, OPC-driven remyelination, hydrogen sulfide pathways in CNS repair, and translational applications of stem cell research. Recent Research Trends: Her articles focus on stem cell-derived therapies for remyelination, endothelial cell contributions to CNS repair, and hydrogen sulfide-based neurotherapeutics. Key themes include iPSC-derived ECs, BDNF/mTORC1 pathways, and rodent models of remyelination. Awards: None explicitly listed, though her work has attracted attention for its impact in regenerative medicine and neuroscience. Advising & Grants: Supervises research students and leads projects on adult brain stem cells in remyelination. Collaborates across institutions to advance translational neuroscience. Labs/Teams: Translational Medicine Research Group (TMRG) and Aston Research Centre for Health in Ageing at AMS.

• Remyelination
• Stem Cell Therapy
• Neuroregeneration
• +3 more

Anthony J. Windebank, M.D., is a Professor of Neurology at Mayo Clinic in Rochester, Minnesota, affiliated with the Mayo Clinic College of Medicine and Science. He serves as a Consultant in the Department of Neurology and holds leadership in faculty development. His research is centered at the Regenerative Neurobiology Laboratory, with collaborative ties to the Mayo Clinic Comprehensive Cancer Center, Neurosurgery, Orthopedic Surgery, and Biochemistry departments. University: Mayo Clinic School: Mayo Clinic College of Medicine and Science Department: Department of Neurology Academic Rank: Professor Dr. Windebank's research focuses on understanding the cellular mechanisms of neuronal death and regeneration in the nervous system. His work spans spinal cord injury, peripheral nerve repair, amyotrophic lateral sclerosis (ALS), and chemotherapy-induced peripheral neuropathy. He utilizes cellular, Drosophila, and rodent models to explore regenerative strategies and translate findings into clinical applications through tissue and cell engineering. His recent publications highlight a strong trend in regenerative neurology, including stem cell therapies for spinal cord injury and ALS, mitochondrial function in neurodegeneration, and exosome-based interventions. These works reflect interdisciplinary efforts combining molecular biology, translational medicine, and clinical neurology. Chemotherapy-Induced Peripheral Neuropathy Spinal Cord Injury and Repair Neural Stem Cell Regeneration Mitochondrial Dysfunction in Neurodegeneration Regulatory Science in Regenerative Medicine Neuroprotective Growth Factors Dr. Windebank has received numerous scientific honors, including the Judith and Jean Pape Adams Charitable Foundation Professorship (2019), an honorary doctorate from Paracelsus Medical University (2010), and the E.T.S. Walton Fellowship (2005). He is also recognized for teaching excellence, having received multiple Teacher of the Year awards and the Distinguished Educator award from Mayo Clinic. He has led major research grants from the National Institutes of Health (NIA, NIBIB, NINDS) and the National Center for Advancing Translational Sciences, supporting projects such as biodegradable polymer implants for spinal cord repair and neuroprotective strategies using IGF-1. He has mentored postdoctoral researchers, medical students, and graduate students, and has held leadership roles in education and research policy at Mayo Clinic. Dr. Windebank is actively involved in professional societies including the Peripheral Nerve Society, American Academy of Neurology, and Society for Neuroscience, and has served on advisory boards for the ALS Association and the Neuropathy Association.

• Neuroregeneration
• Neurodegenerative Diseases
• Peripheral Neuropathy
• +11 more

Dr. Michael Rajnik is a Clinical Professor of Pediatrics at the Uniformed Services University of the Health Sciences in Bethesda, MD. He serves as Division Director for Infectious Disease within the School of Medicine, with academic and clinical expertise focusing on pediatric infectious diseases, epidemiology, and global health initiatives. B.S. Chemistry, King's College (1991) M.D., University of Virginia School of Medicine (1995) Pediatrics Residency, Wilford Hall USAF Medical Center (1998) Pediatric Infectious Diseases Fellowship, National Capital Consortium/USUHS (2001) Dr. Rajnik's research spans pediatric infectious diseases with emphasis on respiratory tract infections, epidemiology, and global health. He has led studies on rotavirus immunization effectiveness, tuberculosis treatment innovations, and pandemic-related healthcare impacts across military populations. His work combines clinical research with public health surveillance and has shaped vaccination and infection control practices within military healthcare systems. Pediatric infectious diseases during wartime, vaccine-preventable illnesses, and multidrug-resistant infections form recurring themes in his research. Recent work focuses on COVID-19 pandemic effects across military pediatric and adult populations, including rotavirus hospitalization trends, cardiac complications, and sexually transmitted infection management. Scientific contributions and recognitions include: Chair, Infectious Diseases Institutional Review Board (2009-2016) Chair, American Academy of Pediatrics Executive Committee (2009-2014) President, Armed Forces Infectious Diseases Society (2007-2008) USAF Master Educator (2007, 2012) Educator of the Year, San Antonio Uniformed Services (2006) As a mentor and Fellowship Director (2006-2016), Dr. Rajnik has guided numerous military physicians in pediatric infectious diseases while leading research administration and advocating for military families within the American Academy of Pediatrics. His clinical and administrative roles demonstrate sustained commitment to advancing military pediatric medicine through education, research, and policy engagement.

• Pediatric Infectious Diseases
• Epidemiology
• Respiratory Tract Infections
• +3 more

Ryoji Amamoto, PhD, is an Assistant Professor of Ophthalmology at Harvard Medical School and an Assistant Scientist at Massachusetts Eye and Ear. His research focuses on retinal degeneration, regenerative neuroscience, and RNA sequencing methodologies. Institution: Harvard Medical School (Massachusetts Eye and Ear) Academic Role: Assistant Professor of Ophthalmology Research Interests: Mechanisms of cone photoreceptor survival in Retinitis Pigmentosa Retinoic acid signaling in ocular development Innovative RNA sequencing techniques (Probe-Seq, FIN-Seq) for cell-type-specific analysis Neuronal regeneration and reprogramming in the central nervous system Scientific Contributions: Developed tools for precise transcriptional profiling of injured or diseased tissues Investigated neurotrophic factors in alcohol consumption models Explored regenerative capacity in adult axolotls and mammalian CNS

• Ophthalmology
• Neuroscience
• Molecular Biology
• +3 more

Jonathan I. Leckenby is an Assistant Professor in the Departments of Surgery (Plastic Surgery) and Neuroscience at the University of Rochester School of Medicine and Dentistry. He holds joint credentials and is affiliated with the UR Medicine Faculty Group and Accountable Health Partners. His research focuses on peripheral nerve regeneration, facial paralysis reanimation, and vascularized composite allotransplantation. He has been involved in groundbreaking work, including pioneering techniques like free functional platysma transfer for eye closure restoration and using 3D electron microscopy to study nerve regeneration. Dr. Leckenby’s academic journey includes degrees from King's College London and St. George's Hospital Medical School, followed by training in plastic surgery and postdoctoral research at Harvard under Jeff Lichtman. Education: Bachelor's in Basic Medical Science and Advanced Human Anatomy, King's College London M.B.B.S., St. George's Hospital Medical School Ph.D. in Neuroscience (postdoctoral, Harvard University) Research Interests: Dr. Leckenby’s lab investigates mechanisms to enhance peripheral nerve regeneration, reduce chemotherapy-induced neuropathy, and improve outcomes in facial paralysis surgery. His work integrates advanced imaging (e.g., diffusion MRI for facial nerve pathways) and 3D microscopy to visualize axonal behavior. Key projects include developing standardized outcome measures for facial reanimation and optimizing immunosuppression in transplant patients. Publications: His 2024 paper on rodent nerve regeneration models highlights advancements in repair techniques. Recent work includes systematic reviews on VCA complications and novel surgical techniques for facial paralysis. His research often bridges clinical practice and laboratory science, aiming to translate findings into patient care. Awards: Recipient of the CMSR Discovery Award (2021), W.G. Stuber Fellowship (2020), and the Wissenschaftpreis (2016). His contributions span international collaborations, including work in Switzerland and the U.S. Grants & Advising: Secured a Department of Defense grant for lymphatic system research in transplantation. Advised over a dozen students/postdocs, including Miranda Chacon and Scott Echternacht. His lab collaborates widely, focusing on translational medicine. Labs/Teams: Lead of the Leckenby Lab, which combines clinical innovation with basic science. Projects include developing an automated facial symmetry index (AFSI) and studying murine models for neuropathy prevention.

• Peripheral Nerve Regeneration
• Facial Paralysis Reanimation
• Vascularized Composite Allotransplantation
• +3 more

Grażyna Biała is a Professor at the Chair and Department of Pharmacology and Pharmacodynamics, Faculty of Pharmacy, Medical University of Lublin. She holds a PharmD and DSc and has been a key figure in pharmacological research, particularly in neuropharmacology and behavioral models of cognitive and psychiatric disorders. Research Interests: Her work centers on understanding drug effects on memory, learning, anxiety, and stress using animal models (mice and rats). She investigates mechanisms involving NMDA receptors, calcium signaling, nicotine, and novel compounds targeting cognitive impairment and mood disorders. Her research integrates pharmacodynamics with behavioral neuroscience to explore both pathological mechanisms and potential therapeutics. The analysis of her recent publications reveals a consistent focus on neuropharmacological interventions in cognitive and affective disorders . Her studies frequently employ rodent models of amnesia, depression, anxiety, and neurodegeneration, evaluating compounds such as nicotine, memantine, flavonoids, and novel heterocyclic derivatives. The keywords across her work emphasize memory, behavior, receptors, animal models, brain, and drug effects , indicating a strong translational orientation toward CNS drug development. Scientific Recognition: ORCID: 0000-0001-8270-9635 Scopus, EuropePMC, Crossref profiles active Approximate Hirsch index (H-index) available via institutional repository Recipient of 4 documented achievements (specifics not detailed) Academic Leadership and Funding: Professor Biała has promoted 11 doctoral theses, indicating significant mentorship in training future scientists. She has led 4 research projects, suggesting sustained grant support and project leadership. Her extensive publication record (397 publications) and patent ownership reflect high productivity and innovation in her field. Laboratory and Research Group: She leads research within the Chair and Department of Pharmacology and Pharmacodynamics, utilizing animal models to study CNS drug actions. Her team likely focuses on behavioral pharmacology, molecular neuropharmacology, and drug screening using transgenic and pharmacologically induced models of neurological and psychiatric conditions.

• Pharmacology
• Pharmacodynamics
• Neuropharmacology
• +9 more